Virtual vs actual networks

Walnut-sized device uses spring-loaded microneedles

The FDA has awarded 510(k) clearance to a new blood-collection device called TAP (Seventh Sense Biosystems). The walnut-sized device attaches to the patient’s arm with an adhesive strip, and uses a ring of 30 spring-loaded microneedles to puncture the skin and withdraw 100 mcL of blood—enough for most blood tests. The product’s manufacturer has described it as “virtually painless.”

The FDA’s approval allows health care workers to use the TAP device to collect capillary blood for hemoglobin A_1c testing, which is routinely used to monitor blood sugar levels in diabetic or prediabetic patients. Seventh Sense Biosystems is working with the FDA to expand the use of TAP to add additional tests as well as at-home collection.

The company’s goal is to lead the “self-collection” movement––enabling blood collection to occur at home, much like the “self-diagnostic” shift in the 1980s when patients could finally perform diagnostic tests at home. The company plans to develop and commercialize future versions of TAP that will allow consumers to collect their own blood anywhere and anytime.

Sources: PR Newswire(link is external); February 23, 2017; and Boston Globe; June 8, 2016.

More Headlines

Repatha Reduces Need for Apheresis in Patients With High LDL-C in Phase 3 Study

Drug inhibits proprotein convertase subtilisin/kexin type 9

FDA Delays Review of Abaloparatide-SC for Postmenopausal Osteoporosis

Agency needs more time to evaluate synthetic peptide

Making Resistant Superbugs Sensitive to Antibiotics

Researchers find new way to restore antibiotic susceptibility in K. pneumoniae and E. coli strains

Congressional Conservatives Threaten to Scuttle Obamacare Repeal

Lawmakers reject “Obamacare Lite”

Trump Taps Scott Gottlieb to Lead FDA

Candidate has strong ties to pharma industry

Workers Would Be Forced To Get Genetic Tests in the Name of Wellness Under Proposed Law

What To Know About Scott Gottlieb, Trump’s Nominee To Head FDA

New Antibiotic Combo Overcomes Drug-Resistant Bacteria

Researchers target carbapenem-resistant Enterobacteriaceae

Report: Top Hospitals Promote Unproven Therapies

Academic centers offer bee venom for fibromyalgia and herbal remedies for Alzheimer’s

The measures most often used today to assess care quality are process measures. Actual outcomes, of course, are harder to measure than whether a certain action has been taken—checking the feet of a patient with diabetes, for example. But many experts don’t think process measures get at the heart of quality.

HEDIS Is the Hassle That Became a Habit

After 25 years, the Healthcare Effectiveness Data and Information Set (HEDIS) is still criticized for focusing on process and taking up doctors’ time. But it has been incorporated into physicians’ workflow and may yet be instrumental in bringing about value-based care.

“Top 15” List Predicts Best-Selling Cancer Drugs in 2022

FiercePharma has compiled a list of the top 15 cancer medications that are expected to dominate the oncology market in 2022.

7 Things You Should Know About the AHCA

House Republicans come out with their ACA alternative. A continuous coverage surcharge replaces the individual mandate. But where’s the CBO score?

The reviews are in! CMS Rating of Hospitals Gets 1.5 Stars

The problem, say hospitals and some analysts, is that rating hospital quality is not so straightforward. How a hospital delivers care is multifactorial and complex, they argue, so trying to cram that into a single score is misleading and can end up like rating a restaurant on its parking.

Far From Over: STDs Have Made a Comeback

Not too long ago, rates for sexually transmitted diseases (STDs) in the United States were at historic lows. Now they are at record highs, and many experts fear they will continue to climb because of meager funding of public health clinics and diminished sex education in schools.

Is Step Therapy a Move In the Wrong Direction?

If insurers insist that doctors use older, lower-cost drugs first, the burden is on the health plan to respond to doctors’ request for different medications quickly, nimbly, and appropriately. But quick and nimble do not often describe insurers’ step-therapy efforts.

For ED, the Doctor Is in But the Men Are Staying Away

Men’s health care changed dramatically after the FDA approved Pfizer’s blue, diamond-shaped Viagra. Suddenly men were interested in seeing their doctors if for only one reason. Now, with restrictions on what some call a lifestyle drug, other health problems go uncharted.

Fake Doctor Roams Boston Hospital

For several days, a middle-aged woman who claimed to be a doctor in training roamed the halls of Brigham and Women’s Hospital in Boston, dressed in scrubs, asking questions at a lecture, attending patient rounds, and observing surgical procedures, according to a report in the Boston Globe

The biosimilar segment of the pharmaceutical industry is on fire. Some 700 biosimilars are at some stage of development, and more than 660 companies are involved in some way in the biosimilars land rush. Still, only a handful may get on the market in the next few years.

Paul Lendner

Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweißen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.

More Headlines

READ NEXT

Leave a Comment Cancel reply